Soteropoulos Paula
SEC CIK 1692444 · EDGAR
BoughtSold
Most active insiders at DNTH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Garcia Marino | CEO AND Pres, Dir | — | $27.96M |
| 2 | Randhawa Simrat | EVP, Head of R, D | — | $15.00M |
| 3 | Savitz Ryan | EVP, CFO, CBO | — | $14.29M |
| 4 | CARR EDWARD | CAO | — | $5.59M |
| 5 | Veness Adam M | SVP, GC, Sec | — | $4.63M |
| 6 | Soteropoulos Paula | Dir | — | $2.25M |
| 7 | McGeorge Anne | Dir | — | $844.8K |
| 8 | Read Simon | Dir | — | $630.8K |
Transactions 19
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-05-11 17:00 | 2026-05-08 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Soteropoulos Paula | Dir | M - OptEx | $8.44 | +599 | 599 | New | +$5,056 |
| DT | 2026-05-11 17:00 | 2026-05-08 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Soteropoulos Paula | Dir | S - Sale+OE | $85.47 | -599 | 0 | -100% | -$51.2K |
| DT | 2026-04-01 17:26 | 2026-03-31 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Soteropoulos Paula | Dir | M - OptEx | $8.44 | +599 | 599 | New | +$5,056 |
| DT | 2026-04-01 17:26 | 2026-03-31 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Soteropoulos Paula | Dir | S - Sale+OE | $80.11 | -599 | 0 | -100% | -$48.0K |
| DT | 2026-03-26 | 2026-03-24 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Soteropoulos Paula | Dir | S - Sale+OE | $78.05 | -27.6K | 0 | -100% | -$2.15M |
| DT | 2026-03-26 | 2026-03-24 | DNTH | Dianthus Therapeutics, Inc. /DE/ | Soteropoulos Paula | Dir | M - OptEx | $8.44 | +27.6K | 27.6K | New | +$232.9K |
| 2024-06-17 | 2024-06-13 | QURE | uniQure N.V. | Soteropoulos Paula | Dir | S - Sale | $5.14 | -2,220 | 20.2K | -10% | -$11.4K | |
| D | 2023-06-20 | 2023-06-13 | QURE | uniQure N.V. | Soteropoulos Paula | Dir | A - Grant | $0.00 | +8,700 | 24.7K | +54% | $0 |
| D | 2023-06-20 | 2023-06-16 | QURE | uniQure N.V. | Soteropoulos Paula | Dir | S - Sale | $18.99 | -2,275 | 22.4K | -9% | -$43.2K |
| 2023-03-01 | 2023-02-27 | QURE | uniQure N.V. | Soteropoulos Paula | Dir | S - Sale | $19.97 | -384 | 16.0K | -2% | -$7,668 | |
| D | 2023-01-20 | 2023-01-18 | QURE | uniQure N.V. | Soteropoulos Paula | Dir | M - OptEx | $5.37 | +6,000 | 22.4K | +37% | +$32.2K |
| D | 2023-01-20 | 2023-01-18 | QURE | uniQure N.V. | Soteropoulos Paula | Dir | S - Sale+OE | $22.59 | -6,000 | 16.4K | -27% | -$135.5K |
| DM | 2022-12-15 | 2022-12-13+ | QURE | uniQure N.V. | Soteropoulos Paula | Dir | M - OptEx | $5.37 | +6,800 | 20.2K | +51% | +$36.5K |
| DM | 2022-12-15 | 2022-12-13+ | QURE | uniQure N.V. | Soteropoulos Paula | Dir | S - Sale+OE | $23.44 | -6,800 | 16.4K | -29% | -$159.4K |
| D | 2022-12-01 | 2022-11-29 | QURE | uniQure N.V. | Soteropoulos Paula | Dir | M - OptEx | — | +6,200 | 22.6K | +38% | — |
| D | 2022-12-01 | 2022-11-29 | QURE | uniQure N.V. | Soteropoulos Paula | Dir | S - Sale+OE | $25.38 | -6,200 | 16.4K | -27% | -$157.4K |
| D | 2022-06-17 | 2022-06-15 | QURE | uniQure N.V. | Soteropoulos Paula | Dir | A - Grant | $0.00 | +9,080 | 16.4K | +124% | $0 |
| 2022-03-02 | 2022-02-28 | QURE | uniQure N.V. | Soteropoulos Paula | Dir | S - Sale | $16.87 | -596 | 7,302 | -8% | -$10.1K | |
| D | 2022-02-28 | 2022-02-24 | QURE | uniQure N.V. | Soteropoulos Paula | Dir | A - Grant | $0.00 | +1,534 | 7,898 | +24% | $0 |
Purchase Sale Sale after option exercise All abbreviations